Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 331061 - 331080 out of 566181 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Italy | (L01DC01) bleomycin | BLEOPRIM*1 flaconcino iniett 15 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | HIKMAFARMACEUTICAS.A. |
| Italy | (L01DC03) mitomycin | MITOMICINA*1 flaconcino infus 10 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACGMBH |
| Italy | (L01DC03) mitomycin | MITOMICINA*1 flaconcino infus 40 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACGMBH |
| Italy | (L01DC03) mitomycin | MITUROX*1 flaconcino polv per soluz endovescicale + sacca solvente | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | MEDACGMBH |
| Italy | (L01EA03) nilotinib (adm: O) | NILOTINIB*112 cps 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAITALIASrl |
| Italy | (L01EA03) nilotinib (adm: O) | NILOTINIB*112 cps 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAITALIASrl |
| Italy | (L01EA03) nilotinib (adm: O) | NILOTINIB*112 cps 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | ACCORDHEALTHCARESLU |
| Italy | (L01EA03) nilotinib (adm: O) | TASIGNA*112 cps 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTISEUROPHARMLTD |
| Italy | (L01EA03) nilotinib (adm: O) | NILOTINIB*112 cps 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | ACCORDHEALTHCARESLU |
| Italy | (L01EA03) nilotinib (adm: O) | TASIGNA*4x28 cps 200 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | NOVARTISEUROPHARMLTD |
| Italy | (L01EB01) gefitinib (adm: O) | GEFITINIB*30 cpr riv 250 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
n/a | TEVAB.V. |
| Italy | (L01EC02) dabrafenib (adm: O) | TAFINLAR*120 cps 50 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NOVARTISEUROPHARMLTD |
| Italy | (L01EC02) dabrafenib (adm: O) | TAFINLAR*120 cps 75 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma | NOVARTISEUROPHARMLTD |
| Italy | (L01EC02) dabrafenib (adm: O) | FINLEE*210 cpr dispersibili 10 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Glioma | NOVARTISEUROPHARMLTD |
| Italy | (L01EC03) encorafenib (adm: O) | BRAFTOVI*28 cps 50 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PIERREFABREMEDICAMENT |
| Italy | (L01EC03) encorafenib (adm: O) | BRAFTOVI*42x1 cps 75 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Melanoma;Colorectal Neoplasms | PIERREFABREMEDICAMENT |
| Italy | (L01ED02) ceritinib (adm: O) | ZYKADIA*90 cps 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | NOVARTISEUROPHARMLTD |
| Italy | (L01ED03) alectinib (adm: O) | ALECENSA*56x4 cps 150 mg | n/a | Retail price with vat |
$0-0 |
$0-0 |
Carcinoma, Non-Small-Cell Lung | ROCHEREGISTRATIONGMBH |
| Italy | (L01EE01) trametinib (adm: O) | SPEXOTRAS*orale polv 1 flacone 0,05 mg/ml 4,7 mg + adattatore + siringa | n/a | Retail price with vat |
$0-0 |
$0-0 |
Glioma | NOVARTISEUROPHARMLTD |
| Italy | (L01EE04) selumetinib | KOSELUGO*60 cps 10 mg flacone | n/a | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1 | ASTRAZENECAAB |
Pages
